JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 11 1002-1006
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klingensmith, W. C.
Right arrow Articles by Wagner, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klingensmith, W. C., III
Right arrow Articles by Wagner, H. N., Jr.

Widespread Abnormalities of Radiocolloid Distribution in Patients with Mucopolysaccharidoses

William C. Klingensmith, III, Edward A. Eikman, Irene Maumenee and Henry N. Wagner, Jr.

The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: William C. Klingensmith III, 615 N. Wolfe St., Baltimore, Md. 21205.

ABSTRACT

Mucopolysaccharidoses (MPS) are inherited disorders of lysosomal enzymes. We have examined the sites of accumulation of intravenously injected 99mTc-sulfur colloid in order to assess the regional distribution of phagocytic function in ten patients with MPS: three with Type I (Hurler), five with Type II (Hunter), one with Type III (Sanfilippo), and one with Type VI (Maroteaux-Lamy). Increased lung up take was observed in 22 of 40 studies (55%) on the five patients with MPS Type II but in none of the 38 studies on patients with other MPS types. All MPS patients had diffuse recticuloendothelial (RE) marrow hypoplasia, despite normal or nearly normal hematocrits and hemoglobin levels, suggesting dissociation of the phagocytic and erythropoietic elements of the marrow. The eight patients with MPS Types I and II all had hepatomegaly and increased splenic uptake. Seven of these patients also had splenomegaly. The two patients with MPS Types III and VI did not have hepatosplenomegaly. These studies indicate that the lysosomal enzymic defect of MPS results in widespread abnormalities of the distribution of phagocytic function in the liver, spleen, bone marrow, and probably the lung as well.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.